4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001193125-26-052128
Director sold 1,225,784 shares at an average $26.64 ($32,658,518)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gold Daniel Allen Director | 2026-02-11 | Sale | −425,000 | $26.67 | $11,334,750 | 15,928,113 | I |
| Gold Daniel Allen Director | 2026-02-12 | Sale | −150,000 | $26.72 | $4,008,000 | 15,778,113 | I |
| Gold Daniel Allen Director | 2026-02-12 | Sale | −275,000 | $26.76 | $7,359,000 | 15,503,113 | I |
| Gold Daniel Allen Director | 2026-02-13 | Sale | −150,784 | $26.49 | $3,994,268 | 15,352,329 | I |
| Gold Daniel Allen Director | 2026-02-13 | Sale | −225,000 | $26.50 | $5,962,500 | 15,127,329 | I |
| Open-market sales · 1,225,784 sh · avg $26.64 · $32,658,518 | |||||||
Loading xslF345X05/ownership.xml…